EDWARDS LIFESCIENCES CORPORATION revenue breakdown overview

EDWARDS LIFESCIENCES CORPORATION revenue for the last year amounted to 101.99 B MXN, the most of which — 65.90 B MXN — came from its highest performing source at the moment, Transcatheter Aortic Valve Replacement, the year earlier bringing 68.62 B MXN. The greatest contribution to the revenue figure was made by United States — last year it brought EDWARDS LIFESCIENCES CORPORATION 59.60 B MXN, and the year before that — 61.10 B MXN.